Thorsten U. Vogel

3.7k total citations · 1 hit paper
42 papers, 2.9k citations indexed

About

Thorsten U. Vogel is a scholar working on Virology, Immunology and Epidemiology. According to data from OpenAlex, Thorsten U. Vogel has authored 42 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Virology, 23 papers in Immunology and 19 papers in Epidemiology. Recurrent topics in Thorsten U. Vogel's work include HIV Research and Treatment (26 papers), Immune Cell Function and Interaction (16 papers) and Influenza Virus Research Studies (13 papers). Thorsten U. Vogel is often cited by papers focused on HIV Research and Treatment (26 papers), Immune Cell Function and Interaction (16 papers) and Influenza Virus Research Studies (13 papers). Thorsten U. Vogel collaborates with scholars based in United States, Germany and Belgium. Thorsten U. Vogel's co-authors include Todd M. Allen, David I. Watkins, David H. O’Connor, John D. Altman, Bianca R. Mothé, Peicheng Jing, Nancy A. Wilson, Alessandro Sette, Austin L. Hughes and Helen Horton and has published in prestigious journals such as Nature, Nature Medicine and The Journal of Immunology.

In The Last Decade

Thorsten U. Vogel

42 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia

2000 565 citations Todd M. Allen, David H. O’Connor et al. profile →

Peers

Thorsten U. Vogel

VIROL

IMMUN

EPIDE

Carol I. Lord United States

Gail P. Mazzara United States

Riri Shibata Japan

Maria G. Salazar United States

Miroslawa Bilska United States

Alicja Trocha United States

Sampa Santra United States

Carol D. Weiss United States

Huxiong Hui United States

Eva G. Rakasz United States

Carol I. Lord United States

Thorsten U. Vogel

1.8k ×0.9

VIROL

1.6k ×0.8

IMMUN

775 ×0.8

EPIDE

674 ×1.0

412 ×0.7

Citations per year, relative to Thorsten U. Vogel Thorsten U. Vogel (= 1×) peers Carol I. Lord

Countries citing papers authored by Thorsten U. Vogel

Since Specialization

Citations

This map shows the geographic impact of Thorsten U. Vogel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thorsten U. Vogel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thorsten U. Vogel more than expected).

Fields of papers citing papers by Thorsten U. Vogel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thorsten U. Vogel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thorsten U. Vogel. The network helps show where Thorsten U. Vogel may publish in the future.

Co-authorship network of co-authors of Thorsten U. Vogel

This figure shows the co-authorship network connecting the top 25 collaborators of Thorsten U. Vogel. A scholar is included among the top collaborators of Thorsten U. Vogel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thorsten U. Vogel. Thorsten U. Vogel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Catani, João Paulo Portela, Tine Ysenbaert, Anouk Smet, et al.. (2023). Anti-neuraminidase and anti-hemagglutinin immune serum can confer inter-lineage cross protection against recent influenza B. PLoS ONE. 18(1). e0280825–e0280825. 6 indexed citations

Smet, Anouk, João Paulo Portela Catani, Tine Ysenbaert, et al.. (2022). Antibodies directed towards neuraminidase restrict influenza virus replication in primary human bronchial epithelial cells. PLoS ONE. 17(1). e0262873–e0262873. 6 indexed citations

Catani, João Paulo Portela, Emma R. Job, Tine Ysenbaert, et al.. (2022). Pre-existing antibodies directed against a tetramerizing domain enhance the immune response against artificially stabilized soluble tetrameric influenza neuraminidase. npj Vaccines. 7(1). 11–11. 7 indexed citations

Nuñez, Ivette A., Michael A. Carlock, James D. Allen, et al.. (2017). Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strains. PLoS ONE. 12(11). e0185666–e0185666. 58 indexed citations

Schotsaert, Michael, Tine Ysenbaert, Anouk Smet, et al.. (2016). Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies. Scientific Reports. 6(1). 24402–24402. 47 indexed citations

Carter, Donald M., Corey J. Crevar, Timothy Alefantis, et al.. (2016). Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses. Journal of Virology. 90(9). 4720–4734. 144 indexed citations

Vogel, Thorsten U., Matthew R. Reynolds, Deborah H. Fuller, et al.. (2003). Multispecific Vaccine-Induced Mucosal Cytotoxic TLymphocytes Reduce Acute-Phase Viral Replication but Fail inLong-Term Control of Simian Immunodeficiency VirusSIVmac239. Journal of Virology. 77(24). 13348–13360. 86 indexed citations

Vogel, Thorsten U., Helen Horton, Deborah H. Fuller, et al.. (2002). Differences Between T Cell Epitopes Recognized After Immunization and After Infection. The Journal of Immunology. 169(8). 4511–4521. 30 indexed citations

Earl, Patricia L., Linda S. Wyatt, David C. Montefiori, et al.. (2002). Comparison of Vaccine Strategies Using Recombinant env–gag–pol MVA with or without an Oligomeric Env Protein Boost in the SHIV Rhesus Macaque Model. Virology. 294(2). 270–281. 75 indexed citations

10.

Horton, Helen, Thorsten U. Vogel, David H. O’Connor, Louis J. Picker, & David I. Watkins. (2002). Analysis of the immune response and viral evolution during the acute phase of SIV infection. Vaccine. 20(15). 1927–1932. 12 indexed citations

11.

Norley, Stephen, Brigitte Beer, Thorsten U. Vogel, et al.. (2002). Vaccine Development Using the Simian Immunodeficiency Virus Model for AIDS. Intervirology. 45(4-6). 267–274. 3 indexed citations

12.

O’Connor, David H., Todd M. Allen, Thorsten U. Vogel, et al.. (2002). Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection. Nature Medicine. 8(5). 493–499. 297 indexed citations

13.

Horton, Helen, William M. Rehrauer, Marian S. Piekarczyk, et al.. (2001). A common rhesus macaque MHC class I molecule which binds a cytotoxic T-lymphocyte epitope in Nef of simian immunodeficiency virus. Immunogenetics. 53(5). 423–426. 10 indexed citations

14.

Allen, Todd M., Bianca R. Mothé, John Sidney, et al.. (2001). CD8⁺Lymphocytes from Simian Immunodeficiency Virus-Infected Rhesus Macaques Recognize 14 Different Epitopes Bound by the Major Histocompatibility Complex Class I Molecule Mamu-A*01: Implications for Vaccine Design and Testing. Journal of Virology. 75(2). 738–749. 132 indexed citations

15.

Allen, Todd M., Thorsten U. Vogel, Deborah H. Fuller, et al.. (2000). Induction of AIDS Virus-Specific CTL Activity in Fresh, Unstimulated Peripheral Blood Lymphocytes from Rhesus Macaques Vaccinated with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen. The Journal of Immunology. 164(9). 4968–4978. 213 indexed citations

16.

Evans, David T., David H. O’Connor, Peicheng Jing, et al.. (1999). Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef. Nature Medicine. 5(11). 1270–1276. 312 indexed citations

17.

Vogel, Thorsten U., et al.. (1999). Major histocompatibility complex class I genes in primates: co‐evolution with pathogens. Immunological Reviews. 167(1). 327–337. 60 indexed citations

18.

Vogel, Thorsten U., et al.. (1998). Presence of circulating CTL induced by infection with wild‐type or attenuated SIV and their correlation with protection from pathogenic SHIV challenge. Journal of Medical Primatology. 27(2-3). 65–72. 10 indexed citations

19.

Denner, Joachim, Christoph Persin, Thorsten U. Vogel, et al.. (1996). The Immunosuppressive Peptide of HIV-1 Inhibits T and B Lymphocyte Stimulation. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 12(5). 442–450. 19 indexed citations

20.

Norley, S., Brigitte Beer, Thorsten U. Vogel, et al.. (1996). Simian Immunodeficiency Virus Live and Inactivated Experimental Vaccines. AIDS Research and Human Retroviruses. 12(5). 447–449. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact